Publications: 458 in 2026-03. -5.5% share of all MeSH-indexed PubMed records vs the same month last year (494 in 2025-03).
PublicationsPubMed
4582026-03
-5.5% share of all MeSH-indexed PubMed records vs same month last year (494 in 2025-03)provisional · settling
0.40% share
The most recent PubMed months are still being indexed. This number will change as they settle.
Counts PubMed records indexed under this disease's MeSH heading, by the month each record was published, as a share of all MeSH-indexed PubMed records that month. MeSH indexing lags about 5 months behind publication; the newest months are still filling in.
You may reuse this chart in your own work as long as the credit line stays intact.
Clinical trials: 48 in 2026-08. -15.8% vs the same month last year (57 in 2025-08).
Clinical trialsClinicalTrials.gov
482026-08
-15.8% vs same month last year (57 in 2025-08)
Counts clinical trials newly registered on ClinicalTrials.gov, by the date each registration was first posted. Scope is global, with no country filter.
You may reuse this chart in your own work as long as the credit line stays intact.
NIH grants: 69 in 2026-08. No percentage shown. No percentage shown: fewer than 24 months on record. The count is ranked in the history held. NIH grants: latest count 69 is in the 80th percentile, running high, versus 15-mo window (2025 to 2026) (provisional, short baseline).
NIH grantsNIH RePORTER
692026-08
80th percentilerunning high, versus 15-mo window (2025 to 2026)short history
Counts NIH awards whose award notice is dated in the month, from NIH RePORTER, matched on the project text. Awards cluster at the end of the federal fiscal year. Scope is the United States. No investigator or contact data is collected.
Download ▾
You may reuse this chart in your own work as long as the credit line stays intact.
Patents: 667 in 2026-08. No percentage shown. No percentage shown: fewer than 24 months on record. The count is ranked in the history held. Patents: latest count 667 is in the 90th percentile, near its historical high, versus 15-mo window (2025 to 2026) (provisional, short baseline).
PatentsPatentsView / USPTO
6672026-08
90th percentilenear its historical high, versus 15-mo window (2025 to 2026)short history
Counts US pre-grant patent applications in the CPC classes mapped to this disease, by the date each application was published, as a share of all US pre-grant applications published that month. A publication reflects a filing about 18 months earlier. The CPC classes are broader than a single disease.
Download ▾
You may reuse this chart in your own work as long as the credit line stays intact.
Preprints: 31 in 2026-08. No percentage shown. No percentage shown: fewer than 24 months on record. The count is ranked in the history held. Preprints: latest count 31 is in the 33rd percentile, in its typical range, versus 15-mo window (2025 to 2026) (provisional, short baseline).
PreprintsmedRxiv / bioRxiv
312026-08
33rd percentilein its typical range, versus 15-mo window (2025 to 2026)short history
Counts new medRxiv and bioRxiv preprints whose title or abstract matches this disease, by posting date, deduplicated across the two servers. History starts at each server's first paper, 2013 for bioRxiv and 2019 for medRxiv. Scope is global. The only author detail kept is the corresponding author's institution.
You may reuse this chart in your own work as long as the credit line stays intact.
How unusual is this?
Each signal's latest reading ranked against this disease's own history
Publications
Publications: latest count 458 is in the 65th percentile, in its typical range, versus 320 months since 2000.
65thpercentile
in its typical range
458/mo · higher than 65% of 320 months since 2000
Clinical trials
Clinical trials: latest count 48 is in the 86th percentile, running high, versus 316 months since 2000.
86thpercentile
running high
48/mo · higher than 85% of 316 months since 2000
NIH grantsprovisional
NIH grants: latest count 69 is in the 80th percentile, running high, versus 15-mo window (2025 to 2026) (provisional, short baseline).
80thpercentile
running high
69/mo · higher than 73% of 15-mo window (2025 to 2026)
Patentsprovisional
Patents: latest count 667 is in the 90th percentile, near its historical high, versus 15-mo window (2025 to 2026) (provisional, short baseline).
90thpercentile
near its historical high
667/mo · higher than 87% of 15-mo window (2025 to 2026)
Preprintsprovisional
Preprints: latest count 31 is in the 33rd percentile, in its typical range, versus 15-mo window (2025 to 2026) (provisional, short baseline).
33rdpercentile
in its typical range
31/mo · higher than 27% of 15-mo window (2025 to 2026)
Publications and Clinical trials are ranked against every month since 2000. NIH grants, Patents and Preprints are ranked against the 15 months we hold and are marked provisional until the full history is loaded.
Recent history
All five signals on a shared 2025 to 2026 window, scoped to the youngest source so each reads at a comparable scaleDownload ▾
You may reuse this chart in your own work as long as the credit line stays intact.
Plot scoped to 2025 to 2026. True monthly spans by source: Publications 2000 to 2026 · 320 mo; Clinical trials 2000 to 2026 · 316 mo; NIH grants 2025 to 2026 · 15 mo; Patents 2025 to 2026 · 15 mo; Preprints 2025 to 2026 · 15 mo.
Publications2000 to 2026 · 320 mopeak 1,158/mo
Clinical trials2000 to 2026 · 316 mopeak 109/mo
NIH grants2025 to 2026 · 15 mobackfill pendingpeak 82/mo
Patents2025 to 2026 · 15 mobackfill pendingpeak 870/mo
Preprints2025 to 2026 · 15 mobackfill pendingpeak 39/mo
Plotted for 2025 to 2026. All five lines share one scale. Row labels show the full span.
Who's driving this
Top organizations behind each signal
Publications
Author institutions · 2023-07..2026-06
10%of works have an industry affiliation
Chinese Academy of Medical Sciences & Peking Union Medical College534
The University of Texas MD Anderson Cancer Center465
Would you read a monthly digest for Non-Small-Cell Lung Cancer?
We are gauging interest in a monthly summary of what moved: new publications, trials, grants, patents and preprints for Non-Small-Cell Lung Cancer. Nothing is sent yet. If enough people ask, we will build it and you will hear first. Your address is used for that and nothing else, and you can ask us to remove it at any time.
Noted. Thanks for the interest in Non-Small-Cell Lung Cancer.
How we map "Non-Small-Cell Lung Cancer"
We used the following search terms for our data.
Publications (PubMed MeSH)
"Carcinoma, Non-Small-Cell Lung"[MeSH Terms] (exploded), counted on the month's [dp] range; heading verified live 2026-09-10
Author institutions (OpenAlex)
topic T10417, T10202; search 'non-small cell lung cancer NSCLC'
Clinical trials (ClinicalTrials.gov)
ConditionSearch: non-small cell lung cancer OR NSCLC OR non-small-cell lung carcinoma OR nonsmall cell lung cancer
NIH grants (RePORTER)
advanced_text_search: non-small cell lung cancer NSCLC